South Asians are more likely to die of atherosclerotic cardiovascular disease (ASCVD) than East Asians or people of European ancestry, according to a new scientific statement published in the American Heart Association’s journal Circulation on May 24.

A smartwatch algorithm reliably differentiated atrial fibrillation (AF) from sinus rhythm among patients scheduled for elective cardioversion, showing the technology’s potential to prevent unnecessary procedures.

An investigational transcatheter mitral valve replacement (TMVR) device helped reduce mitral regurgitation to zero or trace levels in 98.7 percent of patients, according to 30-day follow-up data from the first 100 people scheduled to be treated with Abbott’s Tendyne system.

DUBLIN and PARIS — May 24, 2018 — Investigators today unveiled clinical data from the independently run Onyx 1-Month OCT Study, which showed strong early vessel healing in a patient population that contained a high percentage of patients with complex coronary artery disease who were implanted with the Resolute Onyx(TM) DES at one-month follow-up.

Assessment of coronary physiology to guide revascularization decisions has been linked to lower adverse event rates than using angiography alone, but the adoption of techniques such as fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) continues to lag behind guideline recommendations.

Patients with heart failure who describe themselves as being socially isolated have an increased risk of death and also have an increased use of healthcare resources, according to new research published in the Journal of the American Heart Association on May 23.

Senior citizens who reported exercising at least four times a week throughout their lives showed decreased age-related arterial stiffness when compared to more sedentary individuals, according to a study published May 20 in the Journal of Physiology.

The FDA has issued a Class I recall of the HeartMate 3 Left Ventricular Assist System (Abbott) because a malfunction in the device’s outflow graft assembly could lead to graft occlusion, possibly reducing or stopping blood flow.

Two late-breaking clinical trials presented May 23 at EuroPCR in London demonstrated the ability of renal denervation to significantly lower patients’ blood pressures, regardless of whether they were taking antihypertensive medications.

Pregnancy increases the risk of morbidity in women who exhibit cardiovascular disease (CVD). Complications in expecting mothers may be predicted by a risk index that integrates lesion-specific, delivery-of-care and generic variables.